Cornea/External Disease News

Over in my column The Dry Eye, I’ve embarked on a project to look at the basics of diagnosing and treating dry eye disease.

Hi, I'm Yari, and I have questions, and this is Dr. Marjan Farid, and she has answers. Let's see if they match. Marjan, thank you for being here today.

Post-refractive ectasia is very rare. The incidence is only about 0.1% per 100,000 eyes undergoing LASIK and less than that in eyes undergoing PRK or SMILE.

HCP Cureblindness is rebranding as the Cure Blindness Project, according to a press release.

Eyenovia and Senju Pharmaceutical Co. have announced a collaboration agreement to develop Senju’s SJP-0035 for use with Eyenovia’s Optejet dispensing technology as a combination product to treat chronic dry eye disease.

Anyone who has read any of my drivel knows that I am a long-time fan of testing tear osmolarity to guide the diagnosis and treatment of dry eye disease.

Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release.

Despite being the second-most common rheumatic autoimmune disease in the United States, Sjögren’s syndrome remains under-recognized, with patients often waiting 3 years for a proper diagnosis, according to the Sjögren’s Foundation.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Vince Lombardi: “Gentlemen, we are going back to the very basics of the game. This is a football.”